FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991079897> ?p ?o ?g. }

• W1991079897 endingPage "1396" @default.
• W1991079897 startingPage "1390" @default.
• W1991079897 abstract "The fetal zone is a unique adrenal cortical compartment that exists only during fetal life in humans and higher primates and produces large amounts of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S). Growth of the fetal zone is primarily regulated by ACTH, the actions of which are mediated in part by locally produced autocrine/paracrine growth factors. We previously demonstrated that one of these growth factors, insulin-like growth factor II (IGF-II), is mitogenic for cultured fetal zone cells and is produced in high abundance by these cells in response to ACTH. In the present study, we determined whether IGF-II also modulates the differentiated function of fetal zone cells. We examined the effects of recombinant human IGF-II and the closely related peptide, IGF-I, on 1) basal and agonist-stimulated [ACTH-(1-24), forskolin, or 8-bromo-cAMP] cortisol and DHEA-S production, 2) basal and ACTH-stimulated steady state abundance of messenger ribonucleic acids (mRNAs) encoding the steroidogenic enzymes cytochrome P450 side-chain cleavage (P450scc) and cytochrome P450 17alpha-hydroxylase/17,20-lyase (P450c17), and 3) basal and ACTH-stimulated steady state abundance of mRNA encoding the ACTH receptor. Basal cortisol (23.93 +/- 1.20 pmol/10(5) cells x 24 h) and DHEA-S (548.87 +/- 43.17 pmol/10(5) cells x 24 h) productions were significantly (P < 0.05) increased by IGF-I (2.3- and 1.8-fold, respectively) and IGF-II (2.8- and 1.8-fold, respectively). As expected, ACTH, forskolin, and cAMP markedly increased the production of cortisol by 26-, 10-, and 13-fold, respectively, and that of DHEA-S by 5.4-, 4.6-, and 5.5-fold, respectively, compared with basal levels. IGF-II (100 ng/mL) significantly (P < 0.001) increased ACTH-, forskolin-, and cAMP-stimulated production of cortisol by 2.4-, 4.3-, and 3.2-fold, respectively, and that of DHEA-S by 1.4, 1.6-, and 1.4-fold, respectively. IGF-I (100 ng/mL) had similar effects as IGF-II and significantly (P < 0.001) increased ACTH-, forskolin-, and cAMP-stimulated production of cortisol by 2.8-, 3.9-, and 3.1-fold, respectively, and that of DHEA-S by 1.3-, 1.6-, and 1.4-fold, respectively. The similar potencies of IGF-I and IGF-II suggest that the actions of these factors were mediated via a common receptor, most likely the type I IGF receptor. The effects of IGF-II on ACTH-stimulated steroid production were dose-dependent (EC50, 0.5-1.0 nmol/L), and IGF-II markedly increased the steroidogenic responsiveness of fetal zone cells to ACTH. With respect to cortisol production, IGF-II shifted the ACTH dose-response curve to the left by 1 log10 order of magnitude. IGF-II also increased ACTH-stimulated abundance of mRNA encoding P450scc (1.9-fold) and P450c17 (2.2-fold). Basal expression of P450scc was not affected by IGF-II. In contrast, basal expression of P450c17 was increased 2.2-fold by IGF-II and IGF-I in a dose-responsive fashion. Neither IGF-I nor IGF-II affected basal or ACTH-stimulated abundance of mRNA encoding the ACTH receptor, suggesting that the increase in ACTH responsiveness was not mediated by an increase in ACTH-binding capacity. Taken together, these data indicate that activation of the type I IGF receptor increases ACTH responsiveness in fetal zone cells by modulating ACTH signal transduction at some point distal to ACTH receptor activation. These data also indicate that locally produced IGF-II modulates fetal adrenal cortical cell function by increasing responsiveness to ACTH and possibly (based on its direct stimulation of P450c17 expression) augmenting the potential for adrenal androgen synthesis. Thus, activation of the type I IGF receptor on adrenal cortical cells may play a pivotal role in adrenal androgen production, both physiologically in utero and at adrenarche, and in pathophysiological conditions ofhyperandrogenemia, such as the polycystic ovary syndrome." @default.
• W1991079897 created "2016-06-24" @default.
• W1991079897 creator A5036032139 @default.
• W1991079897 creator A5047191955 @default.
• W1991079897 creator A5073525642 @default.
• W1991079897 creator A5084239794 @default.
• W1991079897 date "1997-05-01" @default.
• W1991079897 modified "2023-10-17" @default.
• W1991079897 title "Insulin-Like Growth Factors Augment Steroid Production and Expression of Steroidogenic Enzymes in Human Fetal Adrenal Cortical Cells: Implications for Adrenal Androgen Regulation1" @default.
• W1991079897 cites W115643999 @default.
• W1991079897 cites W1657952791 @default.
• W1991079897 cites W1963545612 @default.
• W1991079897 cites W1967960775 @default.
• W1991079897 cites W1979420492 @default.
• W1991079897 cites W1979973525 @default.
• W1991079897 cites W1986015863 @default.
• W1991079897 cites W1987860847 @default.
• W1991079897 cites W1994188236 @default.
• W1991079897 cites W2000989152 @default.
• W1991079897 cites W2014319693 @default.
• W1991079897 cites W2024528924 @default.
• W1991079897 cites W2028371091 @default.
• W1991079897 cites W2038430386 @default.
• W1991079897 cites W2048035500 @default.
• W1991079897 cites W2053091130 @default.
• W1991079897 cites W2056005194 @default.
• W1991079897 cites W2064727729 @default.
• W1991079897 cites W2068519652 @default.
• W1991079897 cites W2082025416 @default.
• W1991079897 cites W2087286513 @default.
• W1991079897 cites W2134812217 @default.
• W1991079897 cites W2138910558 @default.
• W1991079897 cites W2400309218 @default.
• W1991079897 cites W64814373 @default.
• W1991079897 cites W6602093 @default.
• W1991079897 doi "https://doi.org/10.1210/jcem.82.5.3948" @default.
• W1991079897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9141522" @default.
• W1991079897 hasPublicationYear "1997" @default.
• W1991079897 type Work @default.
• W1991079897 sameAs 1991079897 @default.
• W1991079897 citedByCount "44" @default.
• W1991079897 countsByYear W19910798972013 @default.
• W1991079897 countsByYear W19910798972016 @default.
• W1991079897 countsByYear W19910798972017 @default.
• W1991079897 countsByYear W19910798972018 @default.
• W1991079897 countsByYear W19910798972019 @default.
• W1991079897 countsByYear W19910798972020 @default.
• W1991079897 crossrefType "journal-article" @default.
• W1991079897 hasAuthorship W1991079897A5036032139 @default.
• W1991079897 hasAuthorship W1991079897A5047191955 @default.
• W1991079897 hasAuthorship W1991079897A5073525642 @default.
• W1991079897 hasAuthorship W1991079897A5084239794 @default.
• W1991079897 hasBestOaLocation W19910798971 @default.
• W1991079897 hasConcept C126322002 @default.
• W1991079897 hasConcept C128240485 @default.
• W1991079897 hasConcept C134018914 @default.
• W1991079897 hasConcept C170493617 @default.
• W1991079897 hasConcept C24998067 @default.
• W1991079897 hasConcept C2776992908 @default.
• W1991079897 hasConcept C2777911890 @default.
• W1991079897 hasConcept C2777977426 @default.
• W1991079897 hasConcept C2779276759 @default.
• W1991079897 hasConcept C2780193516 @default.
• W1991079897 hasConcept C2780657110 @default.
• W1991079897 hasConcept C2780902042 @default.
• W1991079897 hasConcept C526171541 @default.
• W1991079897 hasConcept C62231903 @default.
• W1991079897 hasConcept C71315377 @default.
• W1991079897 hasConcept C71924100 @default.
• W1991079897 hasConcept C7876069 @default.
• W1991079897 hasConcept C80446465 @default.
• W1991079897 hasConcept C86803240 @default.
• W1991079897 hasConceptScore W1991079897C126322002 @default.
• W1991079897 hasConceptScore W1991079897C128240485 @default.
• W1991079897 hasConceptScore W1991079897C134018914 @default.
• W1991079897 hasConceptScore W1991079897C170493617 @default.
• W1991079897 hasConceptScore W1991079897C24998067 @default.
• W1991079897 hasConceptScore W1991079897C2776992908 @default.
• W1991079897 hasConceptScore W1991079897C2777911890 @default.
• W1991079897 hasConceptScore W1991079897C2777977426 @default.
• W1991079897 hasConceptScore W1991079897C2779276759 @default.
• W1991079897 hasConceptScore W1991079897C2780193516 @default.
• W1991079897 hasConceptScore W1991079897C2780657110 @default.
• W1991079897 hasConceptScore W1991079897C2780902042 @default.
• W1991079897 hasConceptScore W1991079897C526171541 @default.
• W1991079897 hasConceptScore W1991079897C62231903 @default.
• W1991079897 hasConceptScore W1991079897C71315377 @default.
• W1991079897 hasConceptScore W1991079897C71924100 @default.
• W1991079897 hasConceptScore W1991079897C7876069 @default.
• W1991079897 hasConceptScore W1991079897C80446465 @default.
• W1991079897 hasConceptScore W1991079897C86803240 @default.
• W1991079897 hasIssue "5" @default.
• W1991079897 hasLocation W19910798971 @default.
• W1991079897 hasLocation W19910798972 @default.
• W1991079897 hasOpenAccess W1991079897 @default.
• W1991079897 hasPrimaryLocation W19910798971 @default.
• W1991079897 hasRelatedWork W1966679294 @default.
• W1991079897 hasRelatedWork W1991079897 @default.

• next